Hubei Topgene Biotechnology Co., Ltd., shorted as Topgenebio, founded in 2009, headquartered at Biolake (Optics Valley) in Wuhan East Lake High-Tech Development Zone, China, is a contract research organization (CRO) featuring non-human primates’(NHPs) experiments and focusing on novel drug research and evaluation. We adhere to the core values of "Service for Medical Innovation & Dedication to Life and Health" and provide integrated R&D services for pharmaceutical campanies. With a broad spectrum of business capability, our services cover breeding of non-human primates, construction of human disease animal models, and a series of non-clinical studies including pharmacological studies, pharmacokinetic studies, drug toxicological studies and safety evaluations, bioanalysis, molecular imaging and analysis, and medical device evaluations.
In the future, we will strive to become a top-tier and internationally renowned comprehensive CRO specializing in new drug research and evaluation. Our mission is to provide a one-stop solution for new drug development that aligns with both domestic and international regulatory standards, serving pharmaceutical companies and research institutions worldwide.